Episode description
Spencer, Razib and Gareth discuss the recent launch of breast cancer susceptibility (BRCA) testing by 23andMe, including the science behind the test and the policy challenges surrounding direct-to-consumer medical testing.
Spencer, Razib and Gareth discuss the recent launch of breast cancer susceptibility (BRCA) testing by 23andMe, including the science behind the test and the policy challenges surrounding direct-to-consumer medical testing.